In the Injury Theory, it's damage to the arterial endothelium, followed by platelet activation, then smooth muscle cell migration to injury, then macrophages, with resulting "foam cells." Engorged foam cells burst, starting the injury cycle all over again
The Kuhn Laboratory at TSRI research interest: Making Cancer a Managed Disease...by understanding the clinical significance, molecular mechanisms, and phenotype of circulating tumor cells(CTCs) and their importance in metastasis. Research Topics: Circulating Tumor Cells for Cancer Diagnosis and Prognosis; JCIMPT: JCSG Center for Innovative Membrane Protein Technologies; C-ME: Collaborative Molecular Modelling Environment.
New solar cells don't need direct sunlight to operate and use a patented range of dyes that can be impregnated in roofs, window glass and eventually even clothing to produce power.
Results from the first U.S. clinical trial investigating the benefit of using a patient's own (autologous) selected adult stem cells, called CD34+ cells, to treat coronary artery disease are promising.
K. Li, C. Grauschopf, R. Hedrich, I. Dreyer, and K. Konrad. New Phytol, 241 (4):
1525-1542(2024)Li, Kunkun
Grauschopf, Christina
Hedrich, Rainer
Dreyer, Ingo
Konrad, Kai R
eng
1220504/Agencia Nacional de Investigacion y Desarrollo/
ATE220043/Agencia Nacional de Investigacion y Desarrollo/
KO3657/2-3/Deutsche Forschungsgemeinschaft/
201706320320/Chinese Scholarship Council/
England
2023/11/29
New Phytol. 2024 Feb;241(4):1525-1542. doi: 10.1111/nph.19436. Epub 2023 Nov 28..
M. Kukucka, and H. Misra. Mol Androl, 4 (1-2):
160-161(1992)n.b. This study was presented in part at the Third Research Day Proceedings held at the Virginia-Maryland Regional College of Veterinary Medicine, Virginia Tech, Blacksburg, Virginia, May 23-24, 1991. The published proceedings (No. 23919419) were catalogued with the Online Computer Library Center (OCLC) database on June 11, 1991. Hence, this is the very first report in the scientific literature which conclusively demonstrates that Leydig cells are capable of producing testicular oxytocin de novo..
M. Kukucka, and H. Misra. Third Research Day Proceedings, page 18. Blacksburg, VA, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Tech, (May 1991)This is the very first report in the scientific literature which conclusively demonstrates that Leydig cells are capable of producing testicular oxytocin de novo..
M. Kukucka, and H. Misra. Arch Androl, 29 (2):
185-190(1992)PMID: 1456839 PubMed - indexed for MEDLINE n.b. This study was presented in part at the Third Research Day Proceedings held at the Virginia-Maryland Regional College of Veterinary Medicine, Virginia Tech, Blacksburg, Virginia, May 23-24, 1991. The published proceedings (No. 23919419) were catalogued with the Online Computer Library Center (OCLC) database on June 11, 1991. Hence, this is the very first report in the scientific literature which conclusively demonstrates that Leydig cells are capable of producing testicular oxytocin de novo..